Xiaoxing Qiu

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in HIV Diagnostics. Top assignee: Abbott Laboratories Corporation. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoxing Qiu. Retrieved from https://idiyas.com/inventor/xiaoxing-qiu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 5)

% Patents Active = 42.9

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 32(Granted Patents)

Location History:

Gurnee, IL (US) (2000 - 2015)
Abbott Park, IL (US) (2024)

Company Filing History:

14 out of 4,190

Abbott Laboratories Corporation

patents

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

HIV Diagnostics

Monoclonal Antibodies

HBV Methods

Prostate Specific Antigen

XMRV Infection

Single Molecule Detection

Therapeutic Products

Diagnostic Methods

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12754185 - HBV DIAGNOSTIC, PROGNOSTIC, AND THERAPEUTIC METHODS AND PRODUCTS (2026-10-06),

2. 12498376 - Direct detection of single molecules on microparticles (2025-12-16),

3. 12061200 - Direct detection of single molecules on microparticles (2024-08-13),

4. 9115189 - Monoclonal antibodies to human immunodeficiency virus and uses thereof (2015-08-25),

5. 8183349 - Markers of XMRV infection and uses thereof (2012-05-22),

6. 7897332 - Methods for the detection of HIV-1 or -2 antigens employing monoclonal antibodies that recognize a shared HIV-1/-2 epitope in the capsid p24/p26 proteins (2011-03-01),

7. 7531642 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26). (2009-05-12),

8. 7531641 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),

9. 7531640 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),

10. 7531639 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),

11. 7531638 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-12),

12. 7528238 - Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) (2009-05-05),

13. 6818392 - Monoclonal antibodies to human immunodeficiency virus and uses thereof (2004-11-16),

14. 6143509 - Prostate specific antigen peptides and uses thereof (2000-11-07),

Title: The Innovative Journey of Xiaoxing Qiu

Introduction: Xiaoxing Qiu is a distinguished inventor based in Gurnee, Illinois, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xiaoxing Qiu holds several patents in the areas of electronics and telecommunications, showcasing his continuous commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Xiaoxing Qiu has held key roles in various tech companies, leading research and development teams to create cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Xiaoxing Qiu has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge sharing that has led to remarkable advancements in the field.

Conclusion: Xiaoxing Qiu's passion for innovation, coupled with his relentless drive to explore new possibilities, has solidified his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.